Form DEF 14A Larimar Therapeutics for: 20 April
Source: Investing.com News
Category macro
Nektar Therapeutics Reports $741.7 Million in Cash and Investments as of April 1
Source: Investing.com News
Form PRE 14A Dentsply Sirona Inc for: 20 April
Source: Investing.com News
Form 144 Roivant Sciences Ltd. for: 20 April
Source: Investing.com News
Form 13D/A SPYRE Therapeutics for: 20 April
Source: Investing.com News
Form PRE 14A Cytomx Therapeutics for: 20 April
Source: Investing.com News
Form 13D/A Eos Energy Enterprises for: 20 April
Source: Investing.com News
Form 144 JABIL INC for: 20 April
Source: Investing.com News
Form 144 Arista Networks for: 20 April
Source: Investing.com News
Form 13G GOLAR LNG LTD for: 20 April
Source: Investing.com News